Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Stallberg, C. Janson, K. Lisspers, G. Johansson, L. Jörgensen, G. Stratelis, G. Telg, K. Larsson (Uppsala, Södertälje, Stockholm, Sweden). Effectiveness of fixed ICS/LABA combinations in COPD – A population based register linkage study. Eur Respir J 2012; 40: Suppl. 56, 740

Member's Comments

No comment yet.

Related content which might interest you: A UK based cost-utility analysis of indacaterol – A once-daily maintenance bronchodilator for patients with COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Interval versus continuous training in individuals with COPD – A systematic review Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 STIT-1: Evaluation of safety and efficacy of short-time TNI treatment in patients with COPD – First interim analysis Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 Differences in therapy for stable COPD across Europe – Results of a multicenter study Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach Year: 2010 Overdiagnosis of severe asthma – single centre study. Preliminary results Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Asthma control and COPD symptom burden: results from a multi-country observational study (SPRINT) in patients using fixed dose combination (FDC) inhalers Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Heart rate analysis using multiscale entropy in OSA patients under CPAP treatment – Pilot study Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 More than half of patients with COPD in Poland are still smoking, only one third is treated according to GOLD recommendations – Results from PulmoScreen study Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Limitation of activities in treated patients with asthma may be underestimated – Results of a cohort study Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT trial Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with medium-dose ICS/LABA therapy (on GINA step 4) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Impact of adherence to fluticasone propionate/salmeterol combination (FSC) therapy on the outcomes of patients with asthma: A population based study Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Assessing the therapeutic benefit of a new inhaled QD LABA through population PK-safety & efficacy modelling Source: Annual Congress 2009 - New bronchodilators Year: 2009 COPD registers and COPD? – Addition of new computer guided consultation software Source: Annual Congress 2010 - From diagnosis to disease management in primary care Year: 2010 A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Beneficial effect of the LAMA/LABA glycopyrronium (GP)/formoterol (FF) fixed-dose combination, delivered using a novel MDI co-suspension technology (GFF MDI), in COPD GOLD group A and B patients Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Cost-effectiveness of single- vs multiple-inhaler triple therapy in a UK COPD population: INTREPID trial Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021